The ROE as of November 2024 (TTM) for Ikena Oncology, Inc. (IKNA) is -39.59%

According to Ikena Oncology, Inc.’s latest financial reports and current stock price. The company's current ROE is -39.59%. This represents a change of 304.90% compared to the average of -9.78% of the last 4 quarters.

Ikena Oncology, Inc. (IKNA) Historical ROE (quarterly & annually)

How has IKNA ROE performed in the past?

The mean historical ROE of Ikena Oncology, Inc. over the last ten years is 9.73%. The current -39.59% ROE has changed -506.69% with respect to the historical average. Over the past ten years (40 quarters), IKNA's ROE was at its highest in in the December 2020 quarter at 25.78%. The ROE was at its lowest in in the September 2020 quarter at -1695.37%.

Ikena Oncology, Inc. (IKNA) ROE by Quarter and Year

Discovering the peaks and valleys of Ikena Oncology, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ikena Oncology, Inc. (IKNA) Average ROE

How has IKNA ROE performed in the past?

The current ROE of Ikena Oncology, Inc. (IKNA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Ikena Oncology, Inc. (IKNA) ROE vs. Peers

How is IKNA’s ROE compared to its peers?

Ikena Oncology, Inc.’s ROE is greater than Edgewise Therapeutics, Inc. (-26.83%), greater than Design Therapeutics, Inc. (-18.01%), greater than Xilio Therapeutics, Inc. (-214.74%), greater than Eliem Therapeutics, Inc. (-47.03%), greater than Monte Rosa Therapeutics, Inc. (-62.68%), greater than Werewolf Therapeutics, Inc. (-58.83%), greater than Stoke Therapeutics, Inc. (-54.45%), greater than Anebulo Pharmaceuticals, Inc. (-184.40%), greater than Celcuity Inc. (-62.66%), greater than MediciNova, Inc. (-20.70%), greater than Rezolute, Inc. (-69.83%), greater than Aerovate Therapeutics, Inc. (-90.19%), greater than Decibel Therapeutics, Inc. (-56.38%), less than Foghorn Therapeutics Inc. (167.93%), greater than Shattuck Labs, Inc. (-61.92%), greater than Kymera Therapeutics, Inc. (-24.96%), greater than Nurix Therapeutics, Inc. (-63.39%),

Build a custom stock screener for Ikena Oncology, Inc. (IKNA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ikena Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ikena Oncology, Inc. (IKNA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ikena Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.